Table 1 Comparison of the preoperative data between patients with and without perioperative myocardial infarction
Non-PMI patients (n = 1122) | PMI patients (n = 59) | P | |
|---|---|---|---|
Age (years) | 54 (48–60) | 57 (51–63) | 0.01 |
Male | 959 (85.47%) | 45 (76.27%) | 0.05 |
BMI (kg/m2) | 27.8 (24.8–30.9) | 28.2 (24.2–33.2) | 0.62 |
BSA (m2) | 1.9 (1.8–2) | 1.9 (1.8–2) | 0.22 |
NYHA III-IV | 326 (29.06%) | 28 (47.46%) | 0.01 |
CCS III-IV | 463 (41.27%) | 32 (54.24%) | 0.049 |
Congestive heart failure | 17 (1.52%) | 5 (8.47%) | ˂ 0.001 |
Previous myocardial infarction | 334 (29.93%) | 19 (32.79%) | 0.65 |
Thrombolysis within 24 h | 9 (0.81%) | 2 (3.51%) | 0.1 |
Previous PCI | 112 (10.02%) | 5 (8.77%) | 0.76 |
Diabetes mellitus | 461 (41.35%) | 31 (52.54%) | 0.09 |
Hypertension | 606 (54.25%) | 40 (67.80%) | 0.04 |
Severe renal impairment/dialysis | 26 (2.33%) | 3 (5.08%) | 0.18 |
COPD | 24 (2.15%) | 3 (5.08%) | 0.15 |
Cerebrovascular disease | 27 (2.42%) | 1 (1.69%) | ˃0.99 |
Peripheral vascular disease | 13 (1.17%) | 2 (3.45%) | 0.17 |
Atrial fibrillation | 4 (0.37%) | 0 | ˃0.99 |
Hemoglobin (mg/dl) | 13.5 (12.4–14.3) | 13.2 (12.4–14.2) | 0.75 |
Creatinine (mg/dl) | 1 (0.9–1.2) | 1 (0.9–1.3) | 0.55 |
Bilirubin (mg/dl) | 0.6 (0.5–0.8) | 0.6 (0.4–0.8) | 0.26 |
Ejection fraction | 0.11 | ||
Good | 846 (77.54%) | 39 (67.24%) | |
Fair | 234 (21.45%) | 18 (31.03%) | |
Poor | 11 (1.01%) | 1 (1.72%) |